Mpox neglect and the smallpox niche: a problem for Africa, a problem for the world.


Journal

Lancet (London, England)
ISSN: 1474-547X
Titre abrégé: Lancet
Pays: England
ID NLM: 2985213R

Informations de publication

Date de publication:
27 05 2023
Historique:
received: 27 09 2022
revised: 15 03 2023
accepted: 16 03 2023
medline: 29 5 2023
pubmed: 6 5 2023
entrez: 5 5 2023
Statut: ppublish

Résumé

Mpox (formerly known as monkeypox) is a zoonotic viral disease endemic in parts of Africa. In May, 2022, the world was alerted to circulation of monkeypox virus in many high-income countries outside of Africa. Continued spread resulted in a WHO declaration of a Public Health Emergency of International Concern. Although there has been much attention on the global outbreak, most of the focus has been on high-income countries outside of Africa, despite the fact that monkeypox virus has been causing disease in parts of Africa for at least 50 years. Furthermore, the long-term consequences of this event, especially the risk that mpox fills the niche vacated through smallpox eradication, have not been sufficiently considered. The heart of the problem is the historical neglect of mpox in Africa where the disease is endemic, and the actual and potential consequences if this neglect is left uncorrected.

Identifiants

pubmed: 37146622
pii: S0140-6736(23)00588-3
doi: 10.1016/S0140-6736(23)00588-3
pmc: PMC10154003
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1822-1824

Informations de copyright

Copyright © 2023 Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of interests DGB is a member of and DLH is an adviser for the WHO Mpox International Health Regulations Emergency Committee. IA and J-JM declare no competing interests.

Auteurs

Ifedayo Adetifa (I)

Nigeria Centre for Disease Control, Abuja, Nigeria.

Jean-Jacques Muyembe (JJ)

Institut National de Recherche Biomédicale, Kinshasa, Democratic Republic of the Congo.

Daniel G Bausch (DG)

FIND, Geneva, Switzerland; Global Health Security Department, London School of Hygiene & Tropical Medicine, London, UK. Electronic address: daniel.bausch@FINDdx.org.

David L Heymann (DL)

Global Health Security Department, London School of Hygiene & Tropical Medicine, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH